Page last updated: 2024-08-22

chromium and Coronary Restenosis

chromium has been researched along with Coronary Restenosis in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (16.67)29.6817
2010's14 (77.78)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Aoki, J; Awata, M; Kashiwabara, K; Kimura, T; Kozuma, K; Matsuyama, Y; Nanasato, M; Oba, K; Shinozaki, T; Shiode, N; Tanabe, K; Yamaguchi, J1
Angiolillo, DJ; Baber, U; Bangalore, S; Bhatt, DL; Chandiramani, R; Claessen, BE; Ge, J; Guedeney, P; Hermiller, J; Kozuma, K; Krucoff, M; Liu, Y; Makkar, R; Mehran, R; Neumann, FJ; Rau, V; Saito, S; Seth, A; Sorrentino, S; Valgimigli, M; Vogel, B; Wang, J1
Aizawa, Y; Fujita, S; Fuse, K; Hatada, K; Ikeda, Y; Kishi, S; Matsubara, T; Okabe, M; Sato, T; Takahashi, M1
Addad, A; Blanchemain, N; Chai, F; Courcot, E; Haulon, S; Laure, W; Lyskawa, J; Martel, B; Simon, N; Sobocinski, J; Taha, M; Woisel, P1
Beleslin, B; Carrie, D; Danzi, GB; Iniguez, A; Macaya, C; Mehmedbegovic, Z; Moreno, R; Putnikovic, B; Schächinger, V; Zeymer, U1
Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C1
Allocco, DJ; Carrié, D; Erglis, A; Hamm, CW; Masotti, M; Mego, D; Underwood, P; Wang, JC; Watkins, MW1
Allocco, DJ; Dawkins, KD; Fang, Q; Gao, R; Han, Y; Hou, Y; Li, H; Wang, H; Xu, B; Yang, Y; Yu, B; Zhang, J1
Allocco, DJ; Ball, M; Bertolet, B; Cannon, LA; Dauber, I; Dawkins, KD; Foster, M; Kereiakes, DJ; Nersesov, AY; Underwood, PL1
Ando, K; Domei, T; Enomoto, S; Hiromasa, T; Hyodo, M; Iwabuchi, M; Kuramitsu, S; Mazaki, T; Shinozaki, T; Shirai, S; Soga, Y; Yamaji, K1
Fraccaro, C; Grossi, P; Mariani, L; Moretti, L; Silenzi, S; Vagnarelli, F1
Hirohata, A; Kataoka, K; Kimura, T; Kozuma, K; Morino, Y; Tanabe, K; Tobaru, T; Yasuda, S1
Abdel-Wahab, M; Geist, V; Kassner, G; Klatt, L; Richardt, G; Sherif, MA; Toelg, R1
Calais, F; Carlsson, J; Götberg, M; James, S; Lagerqvist, B; Nilsson, J; Nilsson, T; Olivecrona, G; Sarno, G; Sjögren, I1
Agostoni, P; Belkacemi, A; Doevendans, PA; Nathoe, HM; Politi, L; Sangiorgi, GM; Shao, C; Stella, PR; Van Belle, E; Voskuil, M; Wildbergh, T1
Horton, JL; Mourtada, F1
Bhargava, B; Karthikeyan, G; Mishra, S; Raju, R; Reddy, NK; Singh, S; Somaraju, B; Virmani, R; Waksman, R1
Baffour, R; Hellinga, D; Pakala, R; Seabron, R; Tio, FO; Waksman, R1

Trials

5 trial(s) available for chromium and Coronary Restenosis

ArticleYear
Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study).
    Journal of interventional cardiology, 2014, Volume: 27, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; France; Humans; Hyperplasia; Male; Middle Aged; Neointima; Prospective Studies; Stents

2014
Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent.
    Cardiovascular revascularization medicine : including molecular interventions, 2015, Volume: 16, Issue:2

    Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Patient Safety; Platinum; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Single-Blind Method; Stents; Survival Rate; Time Factors; Treatment Outcome

2015
PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Volume: 85 Suppl 1

    Topics: Adult; Aged; Cardiovascular Agents; China; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Single-Blind Method; Time Factors; Treatment Outcome

2015
Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Nov-15, Volume: 86, Issue:6

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Bayes Theorem; Chromium; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Patient Selection; Platinum; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Taxus; Time Factors; Treatment Outcome; United States

2015
First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary p
    Journal of the American College of Cardiology, 2012, Jun-19, Volume: 59, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Research Design; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome

2012

Other Studies

13 other study(ies) available for chromium and Coronary Restenosis

ArticleYear
Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent.
    International heart journal, 2019, Sep-27, Volume: 60, Issue:5

    Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Female; Hospitals, University; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Product Surveillance, Postmarketing; Prognosis; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Sirolimus; Survival Analysis; Treatment Outcome

2019
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Circulation, 2020, 03-17, Volume: 141, Issue:11

    Topics: Aged; Aged, 80 and over; Cause of Death; Chromium; Cobalt; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prevalence; Proportional Hazards Models; Prospective Studies; Registries; Smoking; Treatment Outcome

2020
Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt c
    Journal of interventional cardiology, 2018, Volume: 31, Issue:2

    Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Renal Dialysis; Risk Factors; Trace Elements; Treatment Outcome

2018
Mussel inspired coating of a biocompatible cyclodextrin based polymer onto CoCr vascular stents.
    ACS applied materials & interfaces, 2014, Mar-12, Volume: 6, Issue:5

    Topics: Animals; Biocompatible Materials; Bivalvia; Cellulose; Chromium; Cobalt; Coronary Restenosis; Cyclodextrins; Drug Delivery Systems; Drug-Eluting Stents; Humans; Microvessels; Paclitaxel

2014
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 10, Issue:11

    Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators

2015
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation.
    JACC. Cardiovascular interventions, 2015, Aug-17, Volume: 8, Issue:9

    Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Risk Factors; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional

2015
Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.
    Journal of interventional cardiology, 2016, Volume: 29, Issue:3

    Topics: Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Stainless Steel; Stents; Treatment Outcome

2016
Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016, Nov-20, Volume: 12, Issue:10

    Topics: Absorbable Implants; Adult; Aged; Aged, 80 and over; Arginine; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Sulfonamides; Treatment Outcome

2016
Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: results of the COBALT (comparison of bare-metal stents in all-comers' lesion treatment) registry.
    Journal of interventional cardiology, 2011, Volume: 24, Issue:6

    Topics: Aged; Chromium; Cobalt; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Prospective Studies; Registries; Statistics as Topic; Time Factors; Treatment Outcome

2011
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    International journal of cardiology, 2013, Jul-15, Volume: 167, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platinum; Registries; Sirolimus; Sweden; Treatment Outcome

2013
Dose perturbation of a novel cobalt chromium coronary stent on 32P intravascular brachytherapy: a monte carlo study.
    Medical physics, 2005, Volume: 32, Issue:1

    Topics: Brachytherapy; Chromium; Cobalt; Coronary Disease; Coronary Restenosis; Humans; Monte Carlo Method; Phosphorus Radioisotopes; Radiometry; Software; Time Factors

2005
A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 67, Issue:5

    Topics: Analysis of Variance; Animals; Carbon; Chromium; Coated Materials, Biocompatible; Cobalt; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Lactic Acid; Nanostructures; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Stents; Swine

2006
Short-term effects of biocorrodible iron stents in porcine coronary arteries.
    Journal of interventional cardiology, 2008, Volume: 21, Issue:1

    Topics: Animals; Biocompatible Materials; Chromium; Cobalt; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Fibrin; Inflammation; Iron Compounds; Stents; Swine

2008